Business Description
Hansa Biopharma AB
NAICS : 325412
SIC : 2834
ISIN : SE0002148817
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.57 | |||||
Equity-to-Asset | -0.45 | |||||
Debt-to-Equity | -2.53 | |||||
Debt-to-EBITDA | -1.36 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -0.89 | |||||
Beneish M-Score | -2.1 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 160.1 | |||||
3-Year EBITDA Growth Rate | -11.1 | |||||
3-Year EPS without NRI Growth Rate | -16.5 | |||||
3-Year FCF Growth Rate | -27.8 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.75 | |||||
9-Day RSI | 68.76 | |||||
14-Day RSI | 68.97 | |||||
6-1 Month Momentum % | 6.98 | |||||
12-1 Month Momentum % | -47.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.55 | |||||
Quick Ratio | 2.55 | |||||
Cash Ratio | 2.1 | |||||
Days Inventory | 9.55 | |||||
Days Sales Outstanding | 146.17 | |||||
Days Payable | 380.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.8 | |||||
Shareholder Yield % | -12.7 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.8 | |||||
Operating Margin % | -463.1 | |||||
Net Margin % | -509.33 | |||||
FCF Margin % | -444.18 | |||||
ROA % | -71.82 | |||||
ROIC % | -188.35 | |||||
ROC (Joel Greenblatt) % | -2376.08 | |||||
ROCE % | -78.09 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 13.01 | |||||
EV-to-EBIT | -4.31 | |||||
EV-to-Forward-EBIT | -2.45 | |||||
EV-to-EBITDA | -4.31 | |||||
EV-to-Forward-EBITDA | -2.45 | |||||
EV-to-Revenue | 18.05 | |||||
EV-to-Forward-Revenue | 13.9 | |||||
EV-to-FCF | -3.68 | |||||
Price-to-Median-PS-Value | 0.02 | |||||
Earnings Yield (Greenblatt) % | -23.27 | |||||
FCF Yield % | -28.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hansa Biopharma AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 165.881 | ||
EPS (TTM) (kr) | -16.06 | ||
Beta | 2.5 | ||
Volatility % | 65.23 | ||
14-Day RSI | 68.97 | ||
14-Day ATR (kr) | 2.241675 | ||
20-Day SMA (kr) | 34.138 | ||
12-1 Month Momentum % | -47.74 | ||
52-Week Range (kr) | 20.14 - 55.3 | ||
Shares Outstanding (Mil) | 63.15 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hansa Biopharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hansa Biopharma AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Hansa Biopharma AB Frequently Asked Questions
What is Hansa Biopharma AB(OSTO:HNSA)'s stock price today?
When is next earnings date of Hansa Biopharma AB(OSTO:HNSA)?
Does Hansa Biopharma AB(OSTO:HNSA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |